12:00 AM
Nov 25, 2013
 |  BC Week In Review  |  Company News  |  Other News

PixarBio Corp. neurology news

PixarBio launched to develop a platform to achieve sustained release of dopamine or dopamine agonists to treat Parkinson's disease (PD). The...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >